Board meetings, strategic plans, and buyer signals from J. Nalbone’s organization
Jan 21, 2026·BoardMeeting
Board
The University Of Texas At Tyler Institutional Biosafety Committee Meeting
The committee reviewed and approved four amendments to recombinant DNA protocols involving Staphylococcus aureus research and Escherichia coli growth experiments. Discussion for several protocols included requirements for principal investigators to refine scientific objective descriptions and provide clearer justifications for proposed changes. One protocol amendment required the addition of a formal title and clarification regarding the impact of new genetic additions on existing research objectives.
Enterprise
Get verified public-sector contacts at scale
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
The University Of Texas At Tyler Institutional Biosafety Committee Institutional Biosafety Committee Meeting
The committee discussed the scheduling of the upcoming 2025 laboratory inspections for both the main and north campuses. No other business items or reports were presented.
Sep 17, 2025·BoardMeeting
Board
The University Of Texas At Tyler Institutional Biosafety Committee Meeting
The committee reviewed the Institutional Official Review and Research Committee minutes. New business included the review of Recombinant DNA Protocol 265 regarding research on novel genes in inflammatory diseases, which was approved pending specific clarifications on host pathogenicity, vector replication, gene characteristics, safety measures, and chemical handling. Additionally, an addendum to Recombinant DNA Protocol 250-1 was reviewed and approved to update the list of participating investigators.
Jul 16, 2025·BoardMeeting
Board
The University Of Texas At Tyler Institutional Biosafety Committee Meeting Minutes
The committee reviewed the Institutional Official Research Review Committee minutes and discussed a Recombinant DNA protocol regarding the evolution of Escherichia coli. Specific feedback was formulated for the principal investigator, covering experimental documentation, definitions, and biosafety protocols. The protocol was approved pending the required corrections.
Extracted from official board minutes, strategic plans, and video transcripts.
